Related Experiment Videos
Progress in measurement instruments for acute and chronic gout studies
Rebecca Grainger1, William J Taylor, Nicola Dalbeth
1Department of Medicine, University of Otago, and the Malaghan Institute of Medical Research, Wellington 6242, New Zealand.
The Journal of Rheumatology
|October 13, 2009
Summary
Researchers evaluated measurement tools for gout, focusing on pain, swelling, and quality of life. The Medical Outcomes Study Short-Form 36 was endorsed for measuring health-related quality of life in chronic gout patients.
Area of Science:
- Rheumatology
- Clinical Trial Methodology
- Patient-Reported Outcomes
Background:
- Gout research requires standardized measurement tools for accurate assessment.
- The OMERACT (Outcome Measures in Rheumatology) filter provides criteria for evaluating measurement instruments: truth, discrimination, and feasibility.
Purpose of the Study:
- To identify and prioritize measurement domains for acute and chronic gout.
- To assess the technical properties of instruments within the OMERACT framework.
- To discuss findings and plan future research at OMERACT 9.
Main Methods:
- Consensus exercises to identify key measurement domains.
- Technical assessment of instruments against OMERACT criteria (truth, discrimination, feasibility).
- Presentation and discussion at OMERACT 9 gout workshop and related meetings.
Main Results:
- Instruments for pain, swelling, tenderness, and global assessments were evaluated for acute gout.
- Instruments for serum urate, tophus measurement, and health-related quality of life (HRQOL) were validated for chronic gout.
- The Medical Outcomes Study Short-Form 36 was endorsed for HRQOL measurement; tophus measurement methods require further refinement.
Conclusions:
- Validated instruments are available for several key domains in acute and chronic gout.
- Further research is needed for tophus measurement sensitivity and for assessing joint inflammation in acute gout and disability in both forms of gout.
